You're Training Hard and Still Not Improving. Your Genes May Be Why.

PPARGC1A encodes PGC-1 alpha, the master switch that signals your cells to build new mitochondria when you train. When you do a hard aerobic workout, this gene gets activated and triggers the construction of fresh mitochondria. More mitochondria means more aerobic capacity, more fat-burning potential, and better training adaptation.

The Ser variant of PPARGC1A, which approximately 35 to 40% of people carry, impairs this mitochondrial construction process. Your body doesn’t respond to endurance training by building as many new mitochondria as it should, which means your aerobic capacity gains plateau faster and your VO2max improvements stall despite consistent training.

In practical terms, this means long aerobic sessions produce less adaptation for you than they do for someone with the Gly variant. You’re grinding through base-building phases that simply don’t translate into the aerobic gains you’d expect. You might spend months building your weekly mileage only to see minimal improvements in your pace or speed.

ADRB2 encodes the beta-2 adrenergic receptor, the receptor on your fat cells that responds to adrenaline and noradrenaline released during exercise. When you start running, your nervous system floods your body with these catecholamines, which bind to ADRB2 and tell your fat cells to break down fat and release it into your bloodstream as fuel.

Certain ADRB2 variants, carried by approximately 40% of the population, impair this fat-mobilization response. Your fat cells simply don’t respond as effectively to the nervous system’s signal to release stored fat, which means you burn less fat during aerobic work and rely more heavily on carbohydrates. This forces you to eat more carbs to maintain the same training intensity and recovery.

You’ll notice this as a nagging feeling that your body isn’t tapping into fat efficiently during longer sessions. You hit the wall faster than you expect. Your fat stores feel inaccessible even when running at conversational pace. You’re burning through your glycogen stores when you should be in fat-burning zone.

ACTN3 encodes alpha-actinin-3, a structural protein that gives fast-twitch muscle fibers their explosive power. If you carry the X/X genotype, called the null variant, your fast-twitch fibers lack this structural protein entirely. This variant appears in roughly 18% of people with European ancestry.

People with the X/X null variant have fast-twitch fibers that are structurally weaker at explosive power but metabolically more efficient at sustained contractions. This typically means you naturally excel at endurance sports, but you’ll struggle to develop explosive sprint speed or high-power output, no matter how much sprint work you do.

If you have this variant, you probably noticed in your athletic history that long-distance running or cycling felt natural while sprinting felt awkward, even with training. You can build aerobic capacity relatively easily, but adding that final gear of speed seems frustratingly difficult.

VDR encodes the vitamin D receptor, which sits on muscle cells and allows them to respond to vitamin D. Vitamin D is not just a bone-health nutrient; it’s essential for muscle protein synthesis, calcium signaling, and the inflammatory response that follows hard training. Without adequate vitamin D signaling, your muscles can’t repair efficiently from training stress.

Certain VDR variants, present in approximately 30 to 50% of the population depending on which polymorphism, reduce the efficiency of vitamin D signaling in muscle tissue. This means even if your blood vitamin D levels look adequate on paper, your muscles aren’t responding to that vitamin D as well as they should, which slows recovery and blunts training adaptation.

You’ll experience this as delayed soreness after hard training sessions, slower recovery between workouts, and a sense that your body needs more recovery days than teammates following identical training.

MTHFR encodes the enzyme that converts folate into its metabolically active form, which your body uses to produce red blood cells and regulate homocysteine levels. Homocysteine is a byproduct of amino acid metabolism that, in high concentrations, damages the endothelium of blood vessels and impairs oxygen delivery to muscles.

The C677T variant of MTHFR, carried by approximately 40% of people with European ancestry, reduces enzyme function by 40 to 70%. This causes mild homocysteine elevation and impairs your body’s ability to manufacture healthy red blood cells, both of which directly reduce your blood’s oxygen-carrying capacity during aerobic work.

You’ll notice this as a ceiling on your aerobic capacity that doesn’t seem to improve with training. Your VO2max plateaus earlier than expected. Hard efforts feel harder than they should relative to your training volume. Your aerobic pace doesn’t improve even when your fitness clearly has.

SOD2 encodes superoxide dismutase 2, a mitochondrial antioxidant enzyme that neutralizes free radicals produced during aerobic metabolism. When you run hard, your mitochondria produce reactive oxygen species as a byproduct. SOD2 clears these molecules. If SOD2 isn’t working efficiently, these free radicals accumulate and damage muscle proteins, triggering excessive muscle soreness and slowing recovery.

The Val16Ala variant of SOD2, present in approximately 40% of homozygous carriers, impairs this antioxidant function. Your muscles can’t clear oxidative damage as effectively during and after hard training, which means you experience more delayed-onset muscle soreness (DOMS), slower muscle recovery between sessions, and faster fatigue accumulation during training blocks.

You’ve probably noticed that after hard workouts or intense training blocks, your muscle soreness lasts longer than it does for other athletes. Your legs feel heavy for days after a tough session. You need longer recovery windows between hard efforts.